1. Market Research
  2. > Biotechnology
  3. > Genomics Market Trends
  4. > RNA Sequencing: Technologies and Global Markets

RNA Sequencing: Technologies and Global Markets

  • March 2016
  • -
  • BCC Research
  • -
  • 135 pages

Summary

Table of Contents

This BCC Research report provides an overview of the current and future states of the RNA Sequencing (RNA Seq) market for the years 2015, 2016 and 2020 in segments such as instruments, tools and reagents, data analysis, and services.

Use this report to:

Analyze various segments of the RNA-Sequencing market such as RNA-Sequencing tools and reagents, RNA-Sequencing data analysis, and RNA-Sequencing services
Identify the main factors affecting each segment and forecast their market growth, future trends and product development
Evaluate infrastructure for the health and growth of the RNA-Sequencing market as a whole

Highlights

The global RNA-Sequencing market reached nearly $1.1 billion in 2015, and should reach $1.2 billion in 2016 and $2.1 billion in 2020, registering a compound annual growth rate CAGR) of 14.9%.
The tools and reagents segment should reach over $1.0 billion in 2020 from $566.8 million in 2015, a CAGR of 13.0%.
The services segment should reach $460.5 million by 2020 from $170.5 million in 2015, a CAGR of 9.1%.

STUDY GOALS AND OBJECTIVES

This BCC Research report, RNA Sequencing: Technologies and Global Markets, provides an overview of the current and future states of the RNA Sequencing (RNA-Seq) market for the years 2015, 2016 and 2020 in the following segments: instruments, tools and reagents, data analysis, and services. Special emphasis is placed on RNA-Seq technology development because RNA-Seq depends on the development of new and improved high throughput sequencing technologies.

This report describes the available technologies and the major players currently working in the market, as well as detailed analysis of the competitive environments, including new or potential trends in research and product development. This report also includes information regarding opportunities and obstacles affecting this market and its different sectors.

Each of the four RNA-Seq segments has healthy growth potential. Each of them also face serious and unique challenges. This report has a comprehensive discussion of technologies as well as the competitive landscape in the global market. It is designed to aim companies in their strategic planning efforts for exploiting RNA-Seq industry opportunities.

REASONS FOR DOING THE STUDY

RNA-Seq, introduced around 2010, is a method for transcriptomics. In a few short years, it has become the method of choice for transcriptome studies, rapidly replacing another transcriptomics method; the microarray. Transcriptomics is the study of transcriptome, the complete set of RNA transcripts that are produced by the genome, under specific circumstances or in a specific cell, using high-throughput methods.

RNA-Seq not only provides benefits to the scientific research community, but also has huge clinical potential in diagnostics and drug discovery. The RNA-Seq industry is an emerging, evolving and important biomedical sector; a comprehensive and critical study about its technologies and markets is needed for better understanding.

SCOPE AND FORMAT

The geographic scope is global. The RNA-Seq market is complex, consisting of a number of different segments. The market segments are: RNA-Seq instruments; RNA-Seq tools and reagents; RNA-Seq data analysis and RNA-Seq services. Each segment is affected differently by technological and regulatory developments. This
report identifies the main factors affecting each segment and forecasts market growth, future trends and product development in every major market segment. Market forecasts are given for the years 2015, 2016 and 2020.

The report is organized by presenting the core segment (sequencing instruments) first, followed by its derivative segments (tools and reagents, data analysis, services). The development of sequencing instruments is vital for RNA-Seq development; thus sequencing instruments segment is classified as the core segment. However, it does
not suggest that the derivative segments are not important. In fact, the RNA-Seq instruments segment is neither the biggest nor the fastest growing among the four segments. The instruments segment, however, provides the infrastructure for the health and growth of the RNA-Seq market as a whole.

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 60 Million searchable statistics with tables, figures & datasets
  • More than 25,000 trusted sources
Get This Report
24/7 Customer Support

Talk to Veronica

+1 718 514 2762

Purchase Reports From Reputable Market Research Publishers
Non-Invasive Prenatal Testing (NIPT) Market by Instruments (Ultrasound, NGS, PCR, Microarray), Consumables, Method (FCMB, cf-DNA), Application (Trisomy, Microdeletion, Genetics, Rh factor) & End User (Hospital, Diagnostic Labs) - Global Forecast to 2021

Non-Invasive Prenatal Testing (NIPT) Market by Instruments (Ultrasound, NGS, PCR, Microarray), Consumables, Method (FCMB, cf-DNA), Application (Trisomy, Microdeletion, Genetics, Rh factor) & End User (Hospital, Diagnostic Labs) - Global Forecast to 2021

  • $ 5650
  • Industry report
  • March 2017
  • by MarketsandMarkets

The global non-invasive prenatal testing (NIPT) market is projected to reach USD 2.88 billion by 2021 from USD 1.35 billion in 2016, at a CAGR of 16.4% from 2016 to 2021. The major factors driving the ...

Next-Generation Sequencing (NGS) Market by Product (Hiseq, Miseq, Hiseq X Ten/X Five, NextSeq500, Ion Proton, PGM, Ions5, PacBio RSII), Services (Targeted, RNA, Exome, De Novo), & Application (Diagnostics, Biomarker, Agriculture) - Global Forecasts to 202

Next-Generation Sequencing (NGS) Market by Product (Hiseq, Miseq, Hiseq X Ten/X Five, NextSeq500, Ion Proton, PGM, Ions5, PacBio RSII), Services (Targeted, RNA, Exome, De Novo), & Application (Diagnostics, Biomarker, Agriculture) - Global Forecasts to 202

  • $ 5650
  • Industry report
  • April 2017
  • by MarketsandMarkets

The global next-generation sequencing market is estimated to register a CAGR of 20.5% from 2017 to 2022 to reach USD 12.45 billion by 2022. Factors such as technological advancements in NGS platforms, ...

High Throughput Process Development Market by Product & Service (Instrument, Software and Service), Molecule Type (Monoclonal Antibodies, Recombinant Insulin), Process (Upstream, Downstream), End User - Forecast to 2021

High Throughput Process Development Market by Product & Service (Instrument, Software and Service), Molecule Type (Monoclonal Antibodies, Recombinant Insulin), Process (Upstream, Downstream), End User - Forecast to 2021

  • $ 5650
  • Industry report
  • April 2017
  • by MarketsandMarkets

The global high throughput process development market is expected to reach USD 19.78 billion in 2021 from USD 9.91 billion in 2016, at a CAGR of 14.8% from 2016 to 2021. Growth in the high throughput process ...

Global Dpcr Market 2017-2021

March 2017 $ 3500

Download Unlimited Documents from Trusted Public Sources

Genetic Industry in Africa

  • March 2017
    12 pages
  • Genetic  

  • Africa  

    United States  

View report >

Chromosome Industry in the US

  • March 2017
    3 pages
  • Chromosome  

    Genetic Disorde...  

  • United States  

View report >

Genome Sequencing Industry in the US

  • March 2017
    65 pages
  • Genome Sequenci...  

  • United States  

View report >

Genomics Industry

2 months ago

Genomics Industry

3 months ago

Cytogenetic Statistics

4 months ago

Related Market Segments :

Genome Sequencing

ref:plp2016

Reportlinker.com © Copyright 2017. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.